Doug Dollemore

Experimental treatment subdues Type 1 diabetes in laboratory mice

The therapeutic agent converts cells that normally control glucose production into ones that generate insulin.


The overlooked casualties of COVID-19

A new study suggests more than half of health care professionals on the front lines of the pandemic could be at risk for one or more mental health problems.


3i initiative unites university researchers

A university-wide effort brings scientists from diverse backgrounds together to conduct top-tier research in immunology, inflammation and infectious disease.


Empowering rural doctors to treat advanced heart failure improves patient outcomes

Training rural doctors can help heart failure patients who can’t travel for follow-up appointments due to the COVID-19 pandemic.


Broad-spectrum antibiotics and initial pneumonia treatment

Pneumonia patients given drugs that target antibiotic-resistant bacteria in the first few days after hospitalization fared no better than those receiving standard medical care.


Wearable sensor powered by AI predicts worsening heart failure before hospitalization

A wearable sensor that works in conjunction with artificial intelligence technology could help detect critical changes in heart failure patients days before a health crisis.